Accelerate Fund III invests in Fluid Biomed to support the development of its innovative bioabsorbable stent technology for treating brain aneurysms.

Target Company Overview

Fluid Biomed Inc. is a Calgary-based, clinical-stage medical device company that specializes in developing advanced solutions for vascular diseases. Founded by leading neurosurgeons, Dr. John Wong and Dr. Alim Mitha, the company focuses on creating innovative tools to address significant health challenges, particularly brain aneurysms, which pose a major risk of stroke and long-term disability globally. The flagship product, ReSolv™, represents a breakthrough in treatment, being the world’s first bioabsorbable polymer-based stent specifically designed for neurovascular applications.

Fluid Biomed's technology is the result of extensive scientific research and has shown promise in first-in-human clinical trials. This unique stent dissolves over time, thereby enhancing the healing process and providing greater flexibility for future treatments. As demand for safer and more effective medical devices increases, Fluid Biomed is strategically positioned to meet these needs in the healthcare sector.

Industry Overview in Canada

The medical device industry in Canada is a rapidly growing sector, projected to reach nearly CAD 8 billion by 2025. This growth is driven by an increasing prevalence of chronic diseases, advancements in technology, and a fav